newsfilter
← Latest News
PR Newswire·

Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance

Launched Terlivaz® Following U.S. Food and Drug Administration (FDA) Approval in September; Submitted U.S. FDA Premarket Notification Application for Next-Generation Delivery System of INOmax® Strengthened